Last reviewed · How we verify

NCT05675956

Acute Nerve Stimulation For Enhancing Human and Cognitive Performance

Completed NA Last updated 28 March 2024
What this trial tests

NA trial testing Experimental group with 100% intensity setting on Apollo Neuro device in Concussion, Mild in 35 participants. Completed in 27 March 2024.

Timeline
15 January 2023
Primary endpoint
27 March 2024
27 March 2024

Quick facts

Lead sponsorUniversity of South Carolina
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposeother
Enrollment35
Start date15 January 2023
Primary completion27 March 2024
Estimated completion27 March 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of South Carolina

Who can join

Adults 18 to 35, any sex, with Concussion, Mild or Autonomic Nervous System. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to test a wearable device's effect on performance in tactical populations with a history of concussion. The main question it aims to answer is the effectiveness of the device on modulate physiological and cognitive function. The physiological function will be derived from metrics of heart rate variability and blood-based biomarkers, whilst human performance will be evaluated using tasks that assess cognitive domains of executive function, reaction time, and memory.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Concussion, Mild

Currently open trials in the same condition.

Other University of South Carolina trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05675956.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing